In BCM-4664 (PIK3CA-wild-type) PDX model, the addition of L-NMMA to alpelisib did not significantly reduce tumor volume relative to single-agent alpelisib therapy (p = 0.1275) (Fig. 4E). This evidence concerns the gene PIK3CA and neoplasm.